SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Sonny who wrote (3699)11/13/2000 4:44:56 PM
From: Marty R  Respond to of 5665
 
Sonny,

Just trying to understand what you're saying, in your message you mentioned 2 things, the trial results didn't mention anything new and there was a gap in the share price that needed to be filled. So, you think that's why IMGN shares have dropped in price?



To: Sonny who wrote (3699)11/14/2000 9:45:59 AM
From: Marty R  Read Replies (1) | Respond to of 5665
 
Sonny,

Did you stop visiting SI or just not answering my question?



To: Sonny who wrote (3699)11/16/2000 8:47:04 AM
From: Sonny  Read Replies (2) | Respond to of 5665
 
Short-term looks vulnerable as per this chart:

investor.stockpoint.com

We shouldn't be surprised if IMGN re-visits the 20-25 range for a while for technical-consolidation ... massive congestion of red-lines seen in the Nov time frame in the above.

regards to all,
-/Sonny.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News